Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs SYMBIOX INVESTMENT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS SYMBIOX INVESTMENT NOVARTIS/
SYMBIOX INVESTMENT
 
P/E (TTM) x 27.0 -15.7 - View Chart
P/BV x 3.3 0.3 1,201.6% View Chart
Dividend Yield % 4.5 0.0 -  

Financials

 NOVARTIS   SYMBIOX INVESTMENT
EQUITY SHARE DATA
    NOVARTIS
Mar-23
SYMBIOX INVESTMENT
Mar-23
NOVARTIS/
SYMBIOX INVESTMENT
5-Yr Chart
Click to enlarge
High Rs76316 4,902.1%   
Low Rs5543 19,715.3%   
Sales per share (Unadj.) Rs153.41.3 12,053.8%  
Earnings per share (Unadj.) Rs41.90.1 82,383.4%  
Cash flow per share (Unadj.) Rs44.30.1 87,213.6%  
Dividends per share (Unadj.) Rs47.500-  
Avg Dividend yield %7.20-  
Book value per share (Unadj.) Rs314.210.0 3,138.3%  
Shares outstanding (eoy) m24.6931.29 78.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.37.2 59.5%   
Avg P/E ratio x15.7180.8 8.7%  
P/CF ratio (eoy) x14.9180.8 8.2%  
Price / Book Value ratio x2.10.9 228.4%  
Dividend payout %113.50-   
Avg Mkt Cap Rs m16,262288 5,655.7%   
No. of employees `000NANA-   
Total wages/salary Rs m3562 18,562.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,78740 9,511.3%  
Other income Rs m5810 363,187.5%   
Total revenues Rs m4,36940 10,924.0%   
Gross profit Rs m6512 32,703.5%  
Depreciation Rs m610-   
Interest Rs m180-   
Profit before tax Rs m1,1542 53,416.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1201 21,464.3%   
Profit after tax Rs m1,0342 65,006.3%  
Gross profit margin %17.25.0 343.4%  
Effective tax rate %10.426.1 39.9%   
Net profit margin %27.34.0 682.9%  
BALANCE SHEET DATA
Current assets Rs m7,861328 2,395.9%   
Current liabilities Rs m2,68315 18,040.3%   
Net working cap to sales %136.7786.5 17.4%  
Current ratio x2.922.1 13.3%  
Inventory Days Days1,2011,166 103.0%  
Debtors Days Days35730,864 0.0%  
Net fixed assets Rs m12,6560 31,639,750.0%   
Share capital Rs m123313 39.4%   
"Free" reserves Rs m7,6340 2,120,444.4%   
Net worth Rs m7,757313 2,476.4%   
Long term debt Rs m00-   
Total assets Rs m20,517328 6,253.1%  
Interest coverage x66.90-  
Debt to equity ratio x00-  
Sales to assets ratio x0.20.1 152.1%   
Return on assets %5.10.5 1,055.3%  
Return on equity %13.30.5 2,623.1%  
Return on capital %15.10.7 2,193.1%  
Exports to sales %2.10-   
Imports to sales %00-   
Exports (fob) Rs m80NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m800-   
Fx outflow Rs m9460-   
Net fx Rs m-8660-   
CASH FLOW
From Operations Rs m448-45 -1,001.8%  
From Investments Rs m-1,53348 -3,178.1%  
From Financial Activity Rs m-305NA-  
Net Cashflow Rs m-1,3894 -39,694.3%  

Share Holding

Indian Promoters % 0.0 3.3 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 0.7 0.0 -  
FIIs % 0.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 96.7 30.3%  
Shareholders   43,128 26,040 165.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   ADANI ENTERPRISES    REDINGTON    SIRCA PAINTS INDIA    MMTC    LLOYDS ENTERPRISES    


More on Novartis vs SYMBIOX INVESTMENT

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Novartis vs SYMBIOX INVESTMENT Share Price Performance

Period Novartis SYMBIOX INVESTMENT S&P BSE HEALTHCARE
1-Day 1.32% 2.21% 1.16%
1-Month 9.12% -7.36% -0.78%
1-Year 84.40% -25.74% 61.78%
3-Year CAGR 23.75% 42.86% 18.15%
5-Year CAGR 8.81% 36.71% 19.78%

* Compound Annual Growth Rate

Here are more details on the Novartis share price and the SYMBIOX INVESTMENT share price.

Moving on to shareholding structures...

The promoters of Novartis hold a 70.7% stake in the company. In case of SYMBIOX INVESTMENT the stake stands at 3.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Novartis and the shareholding pattern of SYMBIOX INVESTMENT.

Finally, a word on dividends...

In the most recent financial year, Novartis paid a dividend of Rs 47.5 per share. This amounted to a Dividend Payout ratio of 113.5%.

SYMBIOX INVESTMENT paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Novartis, and the dividend history of SYMBIOX INVESTMENT.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.